Welcome to our dedicated page for Hims & Hers Health SEC filings (Ticker: HIMS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hims & Hers Health, Inc. filings document the regulatory record for a public consumer telehealth company offering access to health-and-wellness treatments through its digital platform. Its disclosures include operating and financial results, shareholder letters, material-event reports and clinical or regulatory updates related to products and services available through the platform, including weight loss care.
Proxy and 8-K filings cover board elections, executive compensation, shareholder voting matters, governance practices and capital-structure disclosures. The filing record also documents Class A common stock matters, share repurchase authorizations, material agreements, Regulation FD disclosures and other events affecting the company’s public-company reporting obligations.
Hims & Hers Health, Inc. principal accounting officer Irene Becklund exercised and settled multiple restricted stock unit (RSU) awards into 17,987 shares of Class A Common Stock on March 13, 2026. Each RSU converts into one share of Class A Common Stock.
To cover tax withholding obligations tied to these RSU vestings, 5,832 shares were withheld by the company at a price of $24.77 per share, a non-market, tax-related disposition rather than an open-market sale. Following these transactions, Becklund directly holds 14,281 shares of Class A Common Stock. The RSUs vest based on continued service over four-year schedules with quarterly vesting dates.
Hims & Hers Health, Inc. Chief Executive Officer Andrew Dudum reported the vesting and settlement of restricted stock units on March 13, 2026. The RSU conversions resulted in the acquisition of 164,369 shares of Class A common stock. To cover tax withholding obligations related to these RSUs and performance RSUs that vested on February 23, 2026, the issuer withheld a total of 526,486 shares of Class A common stock at $24.77 per share, which is recorded as a tax-withholding disposition rather than an open-market sale. Following these transactions, Dudum held 1,310,617 Class A shares directly, and also reported additional indirect holdings through several family trusts, including positions such as 3,004,071 shares held by the Trustee of the Dudum Family 2021 Trust and 2,214,769 shares held by the Trustee of the Dudum Family Heritage Trust UAD 8-10-2021.
Hims & Hers Health, Inc. Chief Legal Officer Soleil Boughton reported routine equity compensation activity involving restricted stock units (RSUs) on March 13, 2026. Multiple RSU awards covering a total of 41,421 units were exercised or converted, each RSU representing one share of Class A common stock.
To cover tax withholding obligations tied to the vesting and settlement of these RSUs, the issuer withheld 168,750 shares of Class A common stock at a price of $24.77 per share, classified as tax-withholding dispositions rather than market sales. Following these transactions, Boughton directly holds 313,643 shares of Class A common stock.
Hims & Hers Health, Inc. Chief Financial Officer Oluyemi Okupe reported equity compensation activity involving restricted stock units and Class A Common Stock. On March 13, 2026, RSUs converted into 105,200 shares of Class A Common Stock as they vested under multi‑year service-based schedules.
To cover tax withholding obligations tied to vested performance RSUs and other RSUs, the issuer withheld a total of 283,990 shares of Class A Common Stock at $24.77 per share, characterized as tax-withholding dispositions rather than market sales. Following these transactions, Okupe directly held 323,517 Class A Common shares and indirectly held 7,853 shares through the Oluyemi Okupe Separate Property Trust dated September 1, 2021.
HIMS reported a proposed sale of Class A shares under Rule 144. The filing lists 03/15/2026 vesting of 4,812 Class A shares as restricted stock and identifies a planned sale notification. The filing also records a 02/27/2026 sale by Soleil Boughton of 4,651 Class A shares for $70,741.71.
HIMS reported a Form 144 notifying a proposed sale of Class A common shares. The filing lists $136,511.01 tied to 5,529 Class A shares through Fidelity Brokerage Services with a filing date of 03/17/2026 on the NYSE.
The record also shows a prior disposition by Irene Becklund of 8,411 Class A shares on 12/17/2025 for $308,767.81. The securities listed include restricted shares that vested on 03/15/2026 and are labeled as compensation.
HIMS reported a proposed resale under Form 144 for Class A common stock, showing 97,289 shares listed in the filing as the securities to be sold. The filing notes these shares relate to restricted stock vesting (03/15/2026) and are listed with Fidelity Brokerage Services.
The filing also discloses a prior sale: 13,750 Class A shares were sold on 12/17/2025 for $504,762.50, reported under "Securities Sold During The Past 3 Months." The transaction is identified as a compensation-related disposition in the filing.
Becklund Irene reported acquisition or exercise transactions in this Form 4 filing.
Hims & Hers Health, Inc. reported that PAO Irene Becklund received a grant of 62,076 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Class A Common Stock. These RSUs vest over four years in substantially equal quarterly installments on March 15, June 15, September 15 and December 15, beginning on June 15, 2026, subject to continued service. Following this award, Becklund holds rights relating to 62,076 underlying shares of Class A Common Stock, reflecting a compensation-related equity grant rather than any open-market stock purchase or sale.
Chi Michael reported acquisition or exercise transactions in this Form 4 filing.
Hims & Hers Health, Inc. reported that Chief Operating Officer Michael Chi received a grant of 376,222 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Class A common stock, making this a stock-based compensation award rather than a market purchase.
The RSUs are subject to a service-based vesting schedule over four years, vesting in substantially equal quarterly installments on March 15, June 15, September 15 and December 15, with the first vesting date on June 15, 2026. Following this grant, Chi holds 376,222 RSUs directly.
Autor Deborah M. reported acquisition or exercise transactions in this Form 4 filing.
Hims & Hers Health, Inc. reported that Chief Policy Officer Deborah M. Autor received a grant of 526,711 Restricted Stock Units (RSUs), each representing a right to receive one share of Class A common stock. The RSUs vest over four years in substantially equal quarterly installments on March 15, June 15, September 15 and December 15, beginning on March 15, 2026. Following this award, she holds 526,711 RSUs directly.